During the past decade, Kantonsspital Bruderholz conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kantonsspital Bruderholz" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 25 trials, followed by "Cantonal Hosptal, Baselland" with 3 trials sponsored, "Kantonsspital Baselland Bruderholz" with 2 trials sponsored, "Arteriogenesis Competence Network" with 1 trials sponsored and "Daniel Steinemann, MD" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kantonsspital Bruderholz" #1 collaborator was "Cantonal Hospital of St. Gallen" with 1 trials as a collaborator, "Ente Ospedaliero Cantonale, Bellinzona" with 1 trials as a collaborator, "Kantonsspital Graubuenden" with 1 trials as a collaborator, "Kantonsspital Liestal" with 1 trials as a collaborator and "Luzerner Kantonsspital" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Kantonsspital Bruderholz" are "Lymphoma" (6 trials), "Colorectal Cancer" (5 trials), "Lung Cancer" (4 trials), "Prostate Cancer" (3 trials) and "Esophageal Cancer" (2 trials). Many other conditions were trialed in "Kantonsspital Bruderholz" in a lesser frequency.

Most popular intervention types in "Kantonsspital Bruderholz" are "Drug" (26 trials), "Procedure" (11 trials), "Biological" (10 trials), "Radiation" (6 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "rituximab" (5 trials), "Radiotherapy" (4 trials), "cetuximab" (3 trials), "cisplatin" (3 trials) and "docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kantonsspital Bruderholz" are 33 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kantonsspital Bruderholz". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Kantonsspital Bruderholz, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kantonsspital Bruderholz, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".